Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment

  • So Jin Lee
  • , Myung Sook Huh
  • , Seung Young Lee
  • , Solki Min
  • , Seulki Lee
  • , Heebeom Koo
  • , Jun Uk Chu
  • , Kyung Eun Lee
  • , Hyesung Jeon
  • , Yongseok Choi
  • , Kuiwon Choi
  • , Youngro Byun
  • , Seo Young Jeong
  • , Kinam Park
  • , Kwangmeyung Kim
  • , Ick Chan Kwon

Research output: Contribution to journalArticlepeer-review

156 Scopus citations

Abstract

The condensed version: Thiolated glycol chitosan can form stable nanoparticles with polymerized siRNAs through charge-charge interactions and self-cross-linking (see scheme). This poly-siRNA/glycol chitosan nanoparticles (psi-TGC) provided sufficient in vivo stability for systemic delivery of siRNAs. Knockdown of tumor proteins by psi-TGC resulted in a reduction in tumor size and vascularization.

Original languageEnglish
Pages (from-to)7203-7207
Number of pages5
JournalAngewandte Chemie - International Edition
Volume51
Issue number29
DOIs
StatePublished - 16 Jul 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Antitumor agents
  • Glycol chitosan
  • Nanoparticles
  • Poly-siRNA
  • SiRNA delivery

Fingerprint

Dive into the research topics of 'Tumor-homing poly-siRNA/glycol chitosan self-cross-linked nanoparticles for systemic siRNA delivery in cancer treatment'. Together they form a unique fingerprint.

Cite this